The cohesin subunit Scc1 returns and reconstitutes the complex with Smc1–Smc3 in late mitosis upon DNA double-strand breaks, although it does not participate in homologous recombination-driven MAT ...

Olaparib is indicated for the treatment of certain types of ovarian, breast, pancreatic, and prostate cancers in patients who ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

Olaparib is indicated for the treatment of ovarian, breast, pancreatic, and prostate cancers in patients with specific ...

The research team led by Research Professor Jaeyong Lee at the Institute for Cellular Differentiation and Aging, College of Medicine, Hallym ...

HealthDay News — For patients with metastatic castration-sensitive prostate cancer (mCSPC) with homologous recombination repair (HRR) gene alterations, the addition of niraparib to abiraterone acetate ...

Zydus Lifesciences Ltd announced on Friday (November 7) that it has received tentative approval from the US Food and Drug ...

Zydus receives US FDA tentative approval for olaparib tablets, 100 mg and 150 mg: Our Bureau, Mumbai Saturday, November 8, 2025, 10:30 Hrs [IST] Zydus Lifesciences Limited has rec ...

Bowhead whales, living over two centuries, defy cancer risks due to exceptional DNA repair, not more tumor suppressors. Researchers found their cells ...

The study, titled "Evidence for Improved DNA Repair in Long-Lived Bowhead Whale" , found that whale cells fix DNA breaks with ...